From: Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey
Disease states
Original costs (TL/year)
Year
2009 (TL)
2014a (TL)
Compensated cirrhosis
6778
7857
Decompensated cirrhosis
7573
8780
Hepatocellular carcinoma
31,044
35,989